Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
43.70
+0.20 (0.46%)
At close: May 16, 2025, 4:00 PM
43.75
+0.05 (0.11%)
After-hours: May 16, 2025, 7:49 PM EDT
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $1.84 billion as of May 16, 2025. Its market cap has increased by 49.59% in one year.
Market Cap
1.84B
Enterprise Value
1.50B
1-Year Change
49.59%
Ranking
Category
Stock Price
$43.70
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $1.84B, an increase of 495.83%. That is a compound annual growth rate of 47.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 1.84B | -13.26% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | 839.84M | 172.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| Johnson & Johnson | 364.11B |
| AbbVie | 325.05B |
| Novo Nordisk | 282.81B |
| UnitedHealth Group | 264.80B |
| Abbott Laboratories | 234.53B |
| Novartis AG | 213.43B |
| AstraZeneca | 212.39B |